BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Alzheon Presents Analyses From Phase III Clinical Studies Showing Largest Clinical Effects Of Tramiprosate, The Active Molecule Of ALZ-801, In APOE4/4 Homozygous Patients With Mild Alzheimer’s Disease

  December 9, 2016

   · 

  8 min read
• Policy

  Bristol-Myers Squibb To Pay $19.5M Over Abilify Marketing

  December 9, 2016

   · 

  1 min read
• Biotech Bay

  DNAnexus Reanalyzed World’s Largest Pan-Cancer Initiative Dataset

  December 9, 2016

   · 

  3 min read
• Drug Development

  AstraZeneca Canada Release: Tagrisso (Osimertinib) Demonstrates Superiority Over Chemotherapy In EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer

  December 9, 2016

   · 

  7 min read
• Drug Development

  Cytokinetics Announces New Data Presented At The International Symposium On ALS/MND

  December 9, 2016

   · 

  10 min read
• Pharm Country

  Arvinas Presents Data On Oral Estrogen Receptor PROTAC Degrader At 2016 San Antonio Breast Cancer Symposium

  December 9, 2016

   · 

  2 min read
• Mitsubishi Tanabe Release: 12-month Edaravone Clinical Study Data In ALS Presented At The 27th International Symposium On ALS/MND

  December 9, 2016

   · 

  4 min read
• BioMidwest

  Myriad Genetics Release: The EndoPredict Test Significantly Outperforms The First-Generation Test In Predicting The Risk Of Node-Negative And Node-Positive Breast Cancer Recurrence

  December 9, 2016

   · 

  10 min read
• FDA

  Biogen And AbbVie Receive Health Canada Approval Of Once-Monthly ZINBRYTA (Daclizumab Beta) For Multiple Sclerosis

  December 9, 2016

   · 

  11 min read
• Biotech Bay

  Genomic Health Announces Results From Multiple Oncotype DX Studies, Reinforcing Its Impact In Delivering Precision Medicine To Breast Cancer Patients Around The World

  December 9, 2016

   · 

  9 min read